Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Ipratropium bromide may improve sleep, nocturnal oxygen in COPD patients

May 24, 1999

Different crystalline forms of cipamfylline studied at SB

May 21, 1999

Merck discloses potent, selective and orally active PDE4 inhibitors

May 21, 1999

Positive findings from phase III trial of anti-IgE for allergic rhinitis

May 19, 1999

Inflazyme signs collaborative agreement with HMR for asthma and allergy therapeutics

May 19, 1999

Johnson & Johnson withdraws from norastemizole collaboration

May 18, 1999

SmithKline Beecham describes new series of CCR5 receptor modulators

May 17, 1999

PathoGenesis launches TOBI in second market

May 13, 1999

Asahi Glass describes dual NK1/NK2 antagonists

May 12, 1999

Antiallergic/antiinflammatory agents in the Nikken Chemicals pipeline

May 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...